Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion



Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.



Source link

Raj
Author: Raj

Leave a Reply

Your email address will not be published. Required fields are marked *